Log in
Enquire now
‌

US Patent 8026097 Expansion of NK cells and therapeutic uses thereof

Patent 8026097 was granted and assigned to St. Jude Children's Research Hospital on September, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
0
Date Filed
September 8, 2008
0
Date of Patent
September 27, 2011
0
Patent Application Number
12206204
0
Patent Citations Received
‌
US Patent 12104178 DHFR tunable protein regulation
0
‌
US Patent 11873512 Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease
0
‌
US Patent 12065490 Chimeric antigen receptors and methods of making
0
‌
US Patent 12065492 Anti-B7-H6 antibody, fusion proteins, and methods of using the same
0
‌
US Patent 12070474 Methods and compositions for natural killer cells
0
‌
US Patent 12077785 Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof
0
‌
US Patent 11786582 Human application of engineered chimeric antigen receptor (CAR) T-cells
‌
US Patent 11834676 T cell receptor-deficient T cell compositions
0
‌
US Patent 11872248 Nucleic acids encoding chimeric receptor comprising NKP30 receptor and CD28 and CD3 zeta domains and human T cell containing
0
Patent Inventor Names
Chihaya Imai
0
Dario Campana
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8026097
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 8026097 Expansion of NK cells and therapeutic uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.